Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on March 29, 2007

Stroke. 2007
Published online before print March 29, 2007, doi: 10.1161/STROKEAHA.106.478966
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/5/1621    most recent
STROKEAHA.106.478966v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ardizzone, T. D.
Right arrow Articles by Sharp, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ardizzone, T. D.
Right arrow Articles by Sharp, F. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Acute Cerebral Hemorrhage
Right arrow Behavioral Changes and Stroke

Submitted on November 28, 2006
Accepted on December 14, 2006

Src Kinase Inhibition Improves Acute Outcomes After Experimental Intracerebral Hemorrhage

Timothy D. Ardizzone PhD; Xinhua Zhan MD, PhD; Brad P. Ander PhD; and Frank R. Sharp MD*

From Department of Neurology and the Medical Investigation of Neurodevelopmental Diseases Institute, University of California at Davis, Sacramento, Calif.

* To whom correspondence should be addressed. E-mail: frank.sharp{at}ucdmc.ucdavis.edu.

Background and Purpose--The mechanisms by which intracerebral hemorrhages produce changes of blood flow and metabolism, cell death, and behavioral abnormalities are complex. In this study, we begin to test the hypothesis that intracerebral hemorrhage activates Src kinases that phosphorylate other molecules to produce cell injury and behavioral deficits after intracerebral hemorrhage (ICH).

Methods--ICH was produced in adult Sprague Dawley rats by direct injection of autologous blood (50 µL) into striatum. Src kinase activity, glucose hypermetabolic areas around the ICH, TUNEL-stained cells, and apomorphine-induced rotational behaviors were assessed in animals with ICH pretreated with the Src kinase inhibitor, PP1, or with vehicle.

Results--PP1 (3 mg/kg) blocked increases of Src kinase activity (5-fold) at 3 hours after ICH. PP1 also blocked the areas of glucose hypermetabolism and decreased the numbers of TUNEL-stained cells surrounding the ICH at 24 hours. Finally, apomorphine-induced (1 mg/kg) rotation at 24 hours after ICH was markedly attenuated by previous treatment with PP1 (3 mg/kg intraperitoneal).

Conclusions--PP1 decreases Src kinase activation, glucose metabolic activation, cell death, and behavioral abnormalities after ICH in striatum of adult rats. It is hypothesized that intracerebral hemorrhage, possibly via thrombin activation of protease-activated receptors, activates Src that phosphorylates NMDA receptors, matrix metalloproteinases, and other proteins that mediate injury after ICH.


Key words: apoptosis • behavior • intracerebral hemorrhage • Src-kinase • striatum